Skip to main content

Table 1 General characteristics of pulmonary TB/HIV co-infected patients with positive Xpert spuum test and registered for treatment in 2015 in Beira city, Mozambique

From: Time delay and associated mortality from negative smear to positive Xpert MTB/RIF test among TB/HIV patients: a retrospective study

Characteristics

Number

Percentage (%)

Sex

 Male

167

59.0

 Female

116

41.0

Age groups

 15–24 years old

65

23.0

 25–34 years old

111

39.2

 35–44 years old

50

17.7

 45–54 years old

28

9.9

  > 55 years old

29

10.2

WHO clinical stages of HIV

 Stage 3

120

42.4

 Stage 4

163

57.6

M.tuberculosis/rifampicina (MTB/RIF)

 Resistant

49

17.3

 Not resistant

234

82.7

Highly active antirretroviral therapy (HAART)

 On HAART

164

58.0

 Not on HAART

119

42.0

Treatment outcome

 Died

158

55.8

 Completed

125

44.2

  1. HAART = Highly active antiretroviral therapy, WHO = World health organization